6533b830fe1ef96bd1296fbe
RESEARCH PRODUCT
Reperfusion treatment for high-risk pulmonary embolism associated with COVID-19
Mario MüngerTim SebastianBarco StefanoStefano BarcoNils Kuchersubject
2019-20 coronavirus outbreakbiologyCoronavirus disease 2019 (COVID-19)business.industrySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)biology.organism_classificationmedicine.diseaseVirologyPulmonary embolismPandemicmedicineCardiology and Cardiovascular MedicinebusinessBetacoronavirusCoronavirus Infectionsyear | journal | country | edition | language |
---|---|---|---|---|
2020-06-01 | Vasa |